M1234 – Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia

Long description

Patient has a reactive hcv antibody test, and has a follow up hcv viral test that does not detect hcv viremia

Short description

Pt hcv rctv aby f/u neg

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

Z2 Undefined codes

Added

January 1, 2024

Last change

January 1, 2024 – No change

Nearby M codes

• M1226 – Iop measurement not documented, reason not otherwise specified
• M1227 – Evidence-based therapy was prescribed
• M1228 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, has hcv treatment initiated within 3 months of the reactive hcv antibody test
• M1229 – Patient, who has a reactive hcv antibody test, and has a follow up hcv viral test that detected hcv viremia, is referred within 1 month of the reactive hcv antibody test to a clinician who treats hcv infection
• M1230 – Patient has a reactive hcv antibody test and does not have a follow up hcv viral test, or patient has a reactive hcv antibody test and has a follow up hcv viral test that detects hcv viremia and is not referred to a clinician who treats hcv infection within 1 month and does not have hcv treatment initiated within 3 months of the reactive hcv antibody test, reason not given
• M1231 – Patient receives hcv antibody test with nonreactive result
• M1232 – Patient receives hcv antibody test with reactive result
• M1233 – Patient does not receive hcv antibody test or patient does receive hcv antibody test but results not documented, reason not given
• M1235 – Documentation or patient report of hcv antibody test or hcv rna test which occurred prior to the performance period
• M1236 – Baseline mrs > 2
• M1237 – Patient reason for not screening for food insecurity, housing instability, transportation needs, utility difficulties, and interpersonal safety (e.g., patient declined or other patient reasons)
• M1238 – Documentation that administration of second recombinant zoster vaccine could not occur during the performance period due to the recommended 2-6 month interval between doses (i.e, first dose received after october 31)
• M1239 – Patient did not respond to the question of patient felt heard and understood by this provider and team
• M1240 – Patient did not respond to the question of patient felt this provider and team put my best interests first when making recommendations about my care
• M1241 – Patient did not respond to the question of patient felt this provider and team saw me as a person, not just someone with a medical problem
• M1242 – Patient did not respond to the question of patient felt this provider and team understood what is important to me in my life